What <Product name> contains
The active ingredients in <Product name> are candesartan cilexetil and hydrochlorothiazide.
<Product name> 8 mg/12.5 mg:
One <Product name> tablet contains 8 mg of candesartan cilexetil and 12.5 mg of hydrochlorothiazide.
<Product name> 16 mg/12.5 mg:
One <Product name> tablet contains 16 mg of candesartan cilexetil and 12.5 mg of hydrochlorothiazide.
The other ingredients are:
Lactose monohydrate
Maize starch
Hypromellose 2910 (E464)
Calcium stearate
Hydroxypropyl cellulose (E463)
Disodium edetate
Microcrystalline cellulose (E460)
For <Product name> 16 mg/12.5 mg additionally: ferric oxide red (E172), ferric oxide yellow (E172).
pil-candesartan-hct
What <Product name> looks like and contents of the pack
<Product name> 8 mg/12.5 mg:
White to off white, oval, biconvex, 9.5 x 4.5 mm, bevel edged uncoated tablets with breakline on both sides.
<Product name> 16 mg/12.5 mg:
Peach colored to light orange colored, oval, biconvex, 9.5 x 4.5 mm, bevel edged uncoated tablets with breakline on both sides.
The tablets can be divided into equal halves.
Pack sizes: 10, 14, 28, 30, 50, 56, 60, 98, 100 tablets
Not all pack sizes may be marketed.
Marketing authorisation holder
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Manufacturer
Orion Corporation, Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Marketing authorisation numbers
Candesartan cilexetil/Hydrochloorthiazide Orion 8 mg/12,5 mg tabletten: 107850 Candesartan cilexetil/Hydrochloorthiazide Orion 16 mg/12,5 mg tabletten: 107851
This medicinal product is authorised in the Member States of the EEA under the following names:
This leaflet was last approved in July 2011
pil-candesartan-hct